Regional changes in cerebrovascular resistance during CO2 inhalation and the administration of Aramine in acute cerebrovascular disease.
D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000503:physiopathology*; D006801:Humans; D006940:Hyperemia / Q000209:etiology; D008680:Metaraminol / Q000627:therapeutic use; D014666:Vasomotor System / Q000503:physiopathology*
D008680:Metaraminol